Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma

Am J Hematol. 2010 Jan;85(1):87-90. doi: 10.1002/ajh.21571.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Antineoplastic Agents / adverse effects*
  • Compassionate Use Trials
  • Hodgkin Disease / drug therapy
  • Hodgkin Disease / immunology
  • Hodgkin Disease / pathology*
  • Humans
  • Inflammation / chemically induced
  • Inflammation / drug therapy
  • Inflammation / pathology
  • Lenalidomide
  • Male
  • Neoplasm Recurrence, Local / drug therapy
  • Neoplasm Recurrence, Local / pathology*
  • Thalidomide / adverse effects
  • Thalidomide / analogs & derivatives*
  • Young Adult

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Thalidomide
  • Lenalidomide